Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0A0YQ
|
|||
Drug Name |
CX-8998
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Phase 2 | [1] | |
Essential tremor or related tremors [ICD-11: 8A04.1; ICD-10: G25.0] | Phase 2 | [1] | ||
Parkinson disease [ICD-11: 8A00.0; ICD-10: G20] | Phase 2 | [1] | ||
Company |
Cavion Charlottesville, VA
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated T-type calcium channel (T-CaC) | Target Info | Modulator | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.